SCHEMBL5528291

SCHEMBL5528291

NC(CC(=O)O)C1CCCCC1.[LiH]

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
EPHX1 P07099 3/20 0.43
TP53 P04637 1/20 0.39
GRIK1 P39086 1/20 0.39
DPP4 P27487 5/20 0.38
KDM4E B2RXH2 1/20 0.38
GMNN O75496 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27554280 1.00 ALDH1A1 (0.58) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL6694693 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL7250579 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL5367910 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL7250575 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL5416686 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL7250582 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL1255799 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
SCHEMBL5362998 0.98 ALDH1A1 (0.60) ALDH1A1EPHX1TP53GRIK1DPP4
Hydrochloric Acid SCHEMBL6384019 0.96 ALDH1A1 (0.58) ALDH1A1EPHX1TP53GRIK1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015755-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2007-01-18 US disclosed
EP-1452522-A2 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2004-09-01 EP disclosed
US-20040147745-A1 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2004-07-29 US disclosed
EP-1178958-B1 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARM INC (US) 2004-02-18 EP disclosed
US-20030096796-A1 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-05-22 US disclosed
US-6455502-B1 Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. 2002-09-24 US disclosed
CN-1364155-A N-Cyanomethyl amides as protease inhibitors AXYS PHARM INC (US) 2002-08-14 CN disclosed
EP-1178958-A2 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-02-13 EP disclosed
WO-2000055125-A2 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096796-A1 Novel compounds and compositions as protease inhibitors CTRL, SERPINB1, CPN1 ALDH1A1 4049/4885EPHX1 595/4885TP53 365/4885
US-20040147745-A1 Novel compounds and compositions as protease inhibitors CTRL, SERPINB1, CPN1 ALDH1A1 4049/4885EPHX1 595/4885TP53 365/4885
US-20070015755-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS CTRL, SERPINB1, CPN1 ALDH1A1 4049/4885EPHX1 595/4885TP53 365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.